176 related articles for article (PubMed ID: 31277677)
1. Evaluation of neurofibromatosis type 1 progression using a nationwide registry of patients who submitted claims for medical expense subsidies in Japan between 2008 and 2012.
Yamauchi T; Suka M; Nishigori C; Yanagisawa H
Orphanet J Rare Dis; 2019 Jul; 14(1):166. PubMed ID: 31277677
[TBL] [Abstract][Full Text] [Related]
2. Social Independence of Patients with Neurofibromatosis Type 2 in Japan: Analysis of a National Registry of Patients Receiving Medical Expense Subsidies, 2004-2013.
Okoshi H; Yamauchi T; Suka M; Saito K; Nishigori C; Yanagisawa H
Neurol Med Chir (Tokyo); 2020 Sep; 60(9):450-457. PubMed ID: 32801276
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in patients with neurofibromatosis type 1: a nationwide database study in Japan from 2015 to 2019.
Yamauchi T; Suka M
Environ Health Prev Med; 2023; 28():77. PubMed ID: 38057084
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 1 and childhood cancer.
Matsui I; Tanimura M; Kobayashi N; Sawada T; Nagahara N; Akatsuka J
Cancer; 1993 Nov; 72(9):2746-54. PubMed ID: 8402499
[TBL] [Abstract][Full Text] [Related]
5. Clinical severity in Japanese patients with neurofibromatosis 1 based on DNB classification.
Ehara Y; Yamamoto O; Kosaki K; Yoshida Y
J Dermatol; 2017 Nov; 44(11):1262-1267. PubMed ID: 29098729
[TBL] [Abstract][Full Text] [Related]
6. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
7. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
8. Anthropometric characteristics and comorbidities in Japanese patients with neurofibromatosis type 1: a single institutional case-control study.
Koga M; Koga K; Nakayama J; Imafuku S
J Dermatol; 2014 Oct; 41(10):885-9. PubMed ID: 25201078
[TBL] [Abstract][Full Text] [Related]
9. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.
Friedman JM; Birch PH
Am J Med Genet; 1997 May; 70(2):138-43. PubMed ID: 9128932
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of neurofibromatosis type 1 in the Finnish population.
Kallionpää RA; Uusitalo E; Leppävirta J; Pöyhönen M; Peltonen S; Peltonen J
Genet Med; 2018 Sep; 20(9):1082-1086. PubMed ID: 29215653
[TBL] [Abstract][Full Text] [Related]
11. Loss of social independence in patients with neurofibromatosis type 2: a follow-up study using a national registry in Japan.
Okoshi H; Yamauchi T; Suka M; Yanagisawa H; Fujii M; Nishigori C
Environ Health Prev Med; 2023; 28():46. PubMed ID: 37599081
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
13. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S
Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708
[TBL] [Abstract][Full Text] [Related]
14. Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1.
Ehara Y; Yamamoto O; Kosaki K; Yoshida Y
J Dermatol; 2018 Jan; 45(1):53-57. PubMed ID: 28891076
[TBL] [Abstract][Full Text] [Related]
15. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1.
Yoshida Y; Ehara Y; Koga M; Imafuku S; Yamamoto O
Acta Derm Venereol; 2018 Aug; 98(8):753-756. PubMed ID: 29796689
[TBL] [Abstract][Full Text] [Related]
17. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
18. Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1.
Stevenson DA; Birch PH; Friedman JM; Viskochil DH; Balestrazzi P; Boni S; Buske A; Korf BR; Niimura M; Pivnick EK; Schorry EK; Short MP; Tenconi R; Tonsgard JH; Carey JC
Am J Med Genet; 1999 Jun; 84(5):413-9. PubMed ID: 10360395
[TBL] [Abstract][Full Text] [Related]
19. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
20. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
